Temozolomide Plus Thalidomide in Treating Patients With Recurrent or Progressive Brain Tumor
Clinical trial NCT00006358 · COMPLETED
Trial details
- NCT number
- NCT00006358
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2000-06-13
- Primary completion
- 2003-01-23
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.